Search

Search Constraints

You searched for: Author/Creator Bertotti, Andrea

Search Results

1. Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept, multicentre, open-label, phase 2 trial. Issue 6 (June 2016)

2. INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. Issue 4 (12th April 2019)

3. INKA, an integrative data analysis pipeline for phosphoproteomic inference of active kinases. Issue 5 (24th May 2019)

4. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients. (23rd January 2014)

6. Patient stratification into robust cancer-cell intrinsic subtypes from colorectal cancer biopsies may inform prospective clinical trials. (March 2018)

7. Systems analysis of protein signatures predicting cetuximab responses in KRAS, NRAS, BRAF and PIK3CA wild‐type patient‐derived xenograft models of metastatic colorectal cancer. Issue 10 (13th August 2020)

8. Tankyrase inhibition impairs directional migration and invasion of lung cancer cells by affecting microtubule dynamics and polarity signals. Issue 1 (December 2016)